Douglas Freeman is a partner at Goodwin and a member of the firm’s Private Equity Group. Mr. Freeman’s practice focuses on representing public and private companies, private equity firms and investment banking firms in connection with mergers, acquisitions, public offerings and other corporate transactions in a wide variety of industries. His M&A practice focuses on cross-border mergers, acquisitions, reorganizations and other business combination transactions, with broad experience in leveraged buyouts, listed company transactions and hostile or contested control transactions. Mr. Freeman has been active in a number of “going-private” transactions involving China-based companies listed in the U.S. He also represents issuers and selling shareholders in public offerings of equity and debt securities and private placements, including Rule 144A transactions, and buyers and sellers in connection with in- and out-of-court reorganizations, workouts and restructurings, including distressed mergers, acquisitions and divestitures.

Prior to joining Goodwin in 2017, Mr. Freeman was a partner in the Hong Kong office of Paul Hastings, and previously practiced at Fried Frank and O’Melveny & Myers.

Areas of Practice
TÄTIGKEITSFELDER
业务范围

Experience

ERFAHRUNG

工作经历

Mr. Freeman has served as counsel to:

  • FountainVest Partners in connection with its going private acquisition of Chinese online career platform Zhaopin Limited, together with Hillhouse Capital and SEEK International*
  • FountainVest Partners in a number of transactions, including its establishment of a joint venture in China with WME | IMG, a global sports, fashion and entertainment talent management company, together with Sequoia Capital China and Tencent, and its investments in leading China-based businesses, including Meituan-Dianping, Fangdd.com, and Codoon*
  • the buyer group consortium (consisting of Carlyle, FountainVest Partners, CITIC Capital, Everbright, Fosun International, and the Chairman) in the US$3.7 billion acquisition of Focus Media Holding Limited (NASDAQ: FMCN). The going-private transaction is China’s largest leveraged buyout in history.*
  • Co-investment fund formed by Focus Media and FountainVest Partners in connection with investments in the sports, media and entertainment industries*
  • ZQ Capital its acquisition of Angiotech Pharmaceuticals, Inc., a medical device manufacturer, and its $210 million PIPE investment in NYSE-listed Nu Skin Enterprises*
  • LionRock Capital in connection with numerous transactions*
  • AEA in connection with its acquisition of Three-Sixty Group*
  • Goldman Sachs as financial adviser to the Special Committee of AsiaInfo-Linkage (NASDAQ: ASIA) in the US$890 million acquisition by a consortium led by CITIC Capital Partners*
  • Goldman Sachs as financial adviser to the Special Committee of iSoftStone Holdings Limited (NYSE: ISS) in a pending going private transaction*
  • Goldman Sachs in connection with several principal investments*
  • Lazard as financial adviser to the Special Committee of AutoNavi Holdings Limited in a going private transaction.*
  • Lazard as financial adviser to a buyer group in its acquisition of Yucheng Technologies Limited (NASDAQ: YTEC)*
  • Houlihan Lokey as financial adviser to numerous companies*
  • Duffs & Phelps as financial adviser to numerous companies*
  • the private equity buyer consortium in its going-private acquisition of China jewelry retailer and distributor NASDAQ-listed LJ International*
  • Special Committee of CNinsure (NASDAQ: CISG) in connection with a proposed US$950 million going private transaction involving its chairman and private equity sponsors, including TPG*
  • the independent directors of ChinaCast Education Group (NASDAQ: CAST) in connection with its review of strategic alternatives and crisis management issues*
  • the independent directors of Acorn International (NYSE: ATV), a China-based TV retailer, in connection with its consideration of an unsolicited partial tender offer by its co-founders*
  • Tiens Group, the controlling shareholder of NYSE-listed Tiens Biotech, a China-based manufacturer and distributor of nutritional supplements, in connection with a going private transaction*
  • the Special Committee of Board of Directors of NASDAQ-listed Solarfun Power Holdings, a solar cell producer, in connection with its US$370 million sale of a controlling stake to Hanwha Corporation*
  • a consortium consisting of Sequoia Capital, Citic Capital, and FountainVest Partners in connection with a management-led US$180 million investment in SINA Corporation*

* Denotes experience prior to joining Goodwin.

Recognition

Recognized by Legal 500 Asia Pacific in Corporate M&A, as a Leading Lawyer.

Recognized by Chambers Asia Pacific for Private Equity

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 1995
Harvard Law School
(cum laude)
B.A., 1992
Tufts University
(summa cum laude)

Admissions

Bar

Registered Foreign Lawyer, Hong Kong SAR
New York
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。